Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Solid Cancer × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 423 Breast Neoplasms 266 Neoplasms 258 Colorectal Neoplasms 188 Neoplasm Metastasis 163 Prostatic Neoplasms 154 Ovarian Neoplasms 154 Multiple Myeloma 141 Lung Neoplasms 128 Melanoma 127 Recurrence 122 Stomach Neoplasms 106 Squamous Cell Carcinoma of Head and Neck 103 Endometrial Neoplasms 102 Pancreatic Neoplasms 94 Leukemia, Myeloid, Acute 83 Leukemia, Lymphocytic, Chronic, B-Cell 83 Triple Negative Breast Neoplasms 81 Small Cell Lung Carcinoma 76 Lymphoma, Follicular 74 Lymphoma, Non-Hodgkin 73 Urinary Bladder Neoplasms 70 Lymphoma, Large B-Cell, Diffuse 69 Carcinoma, Hepatocellular 66 Carcinoma, Renal Cell 65 Uterine Cervical Neoplasms 58 Head and Neck Neoplasms 55 Advanced Solid Tumors 55 Parkinson Disease 4, Autosomal Dominant Lewy Body 54 Lymphoma 53

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05947474 2026-02-10

ORB

Orionis Biosciences Inc

Phase 1 Active not recruiting

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡